covid-19

Labs Like Premier Medical Laboratory Services Now Seeing Increased Demand for Various Molecular Diagnostic Tests

~As social distancing measures have decreased, demand for medical tests other than COVID-19 increase~

GREENVILLE, SC September 23, 2020  – At the onset of the pandemic the nation began to practice social distancing, and subsequently, many stopped scheduling visits with their doctors. Laboratories like Premier Medical Laboratory Services suddenly pivoted much of their efforts into providing a high volume of testing for COVID-19. Now, as more businesses and schools have reopened, less of the population has continued to practice extreme social distancing measures. Accordingly, more patients are visiting their physicians’ offices again for routine check-ups and other healthcare needs other than the Coronavirus.

With this, PMLS, recently named one of the Top Genetic Diagnostic Companies of 2020, says that they are beginning to see a rise in demand for tests that they offer to address various medical diagnostic needs aside from COVID-19. Some of these tests included are their pharmacogenomics, advanced cardiovascular testing, and their women’s health & wellness and diabetes panels.

“We are continuing to process up to 50,000 COVID-19 tests per day, but are glad to see an increase in orders for the other tests we provide,” said Kevin Murdock founder of Premier Medical Laboratory Services. “We know that our tests offer vital insight to physicians so that they can best plan the proper care for their patients.”

Including their portfolio of COVID-19 assays, all of PMLS’ tests processed at their 40,000 sqft laboratory are performed with the latest in science and technology to provide the most advanced and comprehensive testing results. For example, PMLS’s MDDiabeticPro panel includes the revolutionary DIABETESpredict test, which is a first of its kind predictive genetic test for type 2 diabetes developed in collaboration with world leading doctors and scientists of Harvard and MIT. The DIABETESpredict test is expected to mark a new era in diabetes prevention and care through evaluating the risk of the disease onset by examining individual genetic profiles and is currently only available to the US through PMLS.

PMLS’s cardiovascular panel, MDHeartPro, offers a more complete look at a patient’s cardiovascular health than the standard lipid profile that is commonly ordered.  In addition to the standard lipid panel, MDHeartPro includes tests that identify plaque buildup, lipid particle size, hereditary factors, and other advanced risk factors.

At PMLS’s fully COLA and CLIA regulated laboratory many of their processes are automated with cutting-edge laboratory equipment. Using a cloud based-laboratory information management system, OnGen, PMLS communicates real-time results to physicians directly from their lab equipment. Because of this, PMLS is able to process hundreds of thousands of COVID-19 tests per month while increasing the testing capacity for their other molecular diagnostic offerings without compromising accuracy or their quick turnaround time of results.

Tagged , , , , , , ,

Premier Medical Laboratory Services Named Among Top Genetic Diagnostic Companies of 2020 by Healthcare Tech Outlook

GREENVILLE, SC August 18, 2020  – Premier Medical Laboratory Services (PMLS) announces today that they have been named one of the Top Genetic Diagnostic Companies of 2020 by Healthcare Tech Outlook, a leading national healthcare publication. The designation, earned by the Greenville, SC laboratory, comes with recognition for their providing the most advanced diagnostic testing solutions with accuracy and efficiency through employing the latest in science and technology.

One of the reasons PMLS was selected by the publication is that they are a highly complex laboratory with various types of test offerings to address many medical diagnostic needs. From COVID-19 PCR tests, antibody testing, pharmacogenomics, advanced cardiovascular testing, and their women’s health & wellness and diabetes panels, all of PMLS’ tests are performed under one roof with cutting-edge laboratory equipment, providing a quick turnaround of results for physicians and patients.

“We are honored to be designated as a top genetic diagnostic company of 2020 by Healthcare Tech Outlook,” said Kevin Murdock, Founder of Premier Medical Laboratory Services. “Our team of scientists and laboratory personnel is continually focused on providing the most advanced solutions to diagnostic testing demands, and to helping physicians provide top-level care to their patients.” 

Along with titling PMLS a top genetic diagnostic company, Healthcare Tech Outlook noted that Premier Medical Laboratory Services’ MDDiabeticPro panel includes the revolutionary DIABETESpredict test, which is a first of its kind predictive genetic test for type 2 diabetes developed in collaboration with world leading doctors and scientists of Harvard and MIT. The DIABETESpredict test is expected to mark a new era in diabetes prevention and care through evaluating the risk of the disease onset by examining individual genetic profiles and is currently available to the US through PMLS.

Along with their MDDiabeticPro panel, the article also recognizes PMLS’ full respiratory pathogen panel and GI panel, as well as their cardiovascular panel MDHeartPro, which more accurately depicts a patient’s overall heart health than a standard lipid panel that is often used by other laboratories. All of these testing services are conducted at PMLS’s 40,000 sqft COLA and CLIA regulated laboratory in Greenville, South Carolina alongside their recently added portfolio of COVID-19 related tests.

By employing the latest in laboratory equipment, added staff and a highly advanced laboratory information management system, OnGen, PMLS has been able to expand their testing capacity and add quality PCR and antibody testing for COVID-19 to their diagnostic testing services. Additionally, the article explores how PMLS has found solutions to overcome COVID-19 supply chain shortages in coordination with their sister company, CPT Medical, who makes their own viral transport media and specimen collection kits.

Healthcare Tech Outlook states, “PMLS is a highly sophisticated and top of the line advanced diagnostics lab” with “robust diagnostic services.”

To read the full article, please visit this link: https://bit.ly/2POMkYW.

For more information about Premier Medical Laboratory Services, please visit www.PreMedInc.com or call 1.877.335.2455.

###

ABOUT PREMIER MEDICAL LABORATORY

Premier Medical Laboratory Services (PMLS) is a CLIA and COLA regulated laboratory based in Greenville, South Carolina focused on providing clinically meaningful results to medical practitioners. Premier Medical Laboratory Services offers a variety of highly specialized tests including: the only Type II Diabetes molecular predisposition test available in the U.S., advanced cardiovascular testing, hereditary cancer screening, carrier screening, women’s health panels, pharmacogenomics, serum allergy testing, blood wellness, Hepatitis C genotyping, respiratory pathogens, gastrointestinal pathogens, and more. In addition to its specialty programs, Premier Medical Laboratory offers a comprehensive testing menu of general chemistry, immunoassay, and hematology tests. The company also is proud to offer a patient friendly billing policy.

For more information, please visit www.PreMedInc.com or call 1.877.335.2455.

Tagged , , , , , ,

Premier Medical Laboratory Services Doubles Antibody Test Capacity with OnGen Cloud-based Tech

GREENVILLE, SC July 15, 2020 – As a growing amount of COVID-19 antibody tests are being administered, antibody testing efficiency is increasingly critical. Premier Medical Laboratory Services (PMLS), a leading commercial diagnostic laboratory, has found a way to increase their antibody testing capacity to now process 50,000 per day while decreasing their turnaround time – providing results in under 48 hours. PMLS has reached this level of efficiency by implementing a cloud-based laboratory information management system (LIMS), OnGen. OnGen LIMS interfaces directly with laboratory equipment, automating data entry, quality control, scheduling, and billing, streamlining their workflow.

Because OnGen integrates seamlessly with any electronic medical record system (EMR) that hospitals and physicians’ offices currently use, testing orders can be entered and communicated directly to laboratory instruments with modules that provide real-time results. That’s why PMLS is able to deliver antibody test results with an expedited turnaround time to physicians for their patients. Laboratories across the nation can drastically expand their workflow and bring antibody testing as well as COVID-19 PCR testing to an exponentially higher amount of patients that need it by implementing OnGen’s advanced LIMS.

“OnGen is the technology solution that we found most effective in automating many of our lab processes that would otherwise be done manually,” Kevin Murdock, Founder of Premier Medical Laboratory said. “We encourage other laboratories to use OnGen LIMS so that we can all better serve physicians who are providing vital COVID-19 antibody and PCR testing in battle against this pandemic.”

PMLS’s antibody test, or Immunoglobulin G/Immunoglobulin M enzyme-linked immunosorbent assay (IgG/IgM ELISA), was granted Emergency Use Authorization (EUA) by the Food and Drug Administration (FDA) one month ago. It requires a blood draw administered by a physician or staff which is then sent to PMLS for the IgG/IgM ELISA. Results are provided within 24 – 48 hours upon lab receipt of the testing sample and determine if there is a presence of antibodies in the patient sample – indicating that the patient had a past infection of the COVID-19 virus and could potentially be immune to a reinfection. PMLS plans to increase their antibody testing capacity with OnGen to 100,000 serologic tests per day in the next two weeks. 

Information about OnGen LIMS:

  • fully HIPAA compliant
  • Can seamlessly work with any Electronic Medical Record (EMR) system
  • Has a physician outreach portal to ensure doctors can freely access information for their patients
  • Allows administrators to set multiple levels of access so unauthorized access of patient information is blocked
  • Includes modules that automate quality control, scheduling, testing and billing

Hospitals and physicians offices can provide COVID-19 antibody testing or PCR testing by clicking on the following link for easy account activation with Premier Medical Laboratory Services: www.premedinc.com/covid-19

Tagged , ,

Leading South Carolina Laboratory, Premier Medical Laboratory Services, Now Providing COVID-19 Antibody Testing

GREENVILLE, SC June 9, 2020 – Premier Medical Laboratory Services, a top commercial diagnostic laboratory is now expanding their COVID-19 testing portfolio by adding antibody testing to their offerings. With a recent increase in their testing capacity to 620,000 COVID-19 tests per month, the addition of their antibody test, or Immunoglobulin G/Immunoglobulin M enzyme-linked immunosorbent assay (IgG/IgM ELISA), aids in their mission to help the state of South Carolina and the US at large safely reopen.

Premier Medical Laboratory Services’ (PMLS) antibody testing, which was granted Emergency Use Authorization (EUA) by the Food and Drug Administration (FDA), requires a blood draw administered by a physician or staff which is then sent to PMLS for the IgG/IgM ELISA. Results are provided within 24 – 48 hours upon lab receipt of the testing sample and determine if there is a presence of antibodies in the patient sample – indicating that the patient had a past infection of the COVID-19 virus and could potentially be immune to a reinfection.

“Because gathering data on COVID-19 to understand its complexities is so important in overcoming it, we are dedicated to offering every effective testing resource we can,” said Kevin Murdock, founder of PMLS. “We are determined in doing our part for the safe reopening of America and will continue meeting COVID-19 head-on with the latest in technology and science.”

An ideal candidate for the antibody test is someone who believes they already have had the COVID-19 virus. Anyone currently experiencing COVID-19 symptoms should not take an antibody test, but rather, should take the PCR test to determine if they currently have the COVID-19 virus. According to the CDC, antibody testing should be conducted 1-3 weeks after infection, since it can take that amount of time for the body to produce antibodies.

Aside from determining potential immunity from a reinfection of COVID-19, the other benefits to receiving antibody testing are:

  • To help guide doctors in providing the correct clinical care for specific patient needs
  • To help provide researchers and healthcare professionals further understanding of COVID-19
  • To determine a patient’s ability to donate antibody-rich plasma which can be used in convalescent plasma therapy, potentially helping other patients overcome COVID-19
  • To help in developing a vaccine for COVID-19

Along with antibody testing, Premier Medical Laboratory Services also recently introduced (in partnership with Vessel Medical) a comprehensive COVID-19 safety program to equip businesses with the latest in testing, safety, and monitoring for returning employees to work – MDHealthPro Opening Up America Again.

Hospitals and physicians offices can provide COVID-19 PCR testing or antibody testing by clicking on the following link for easy account activation with PMLS: www.premedinc.com/covid-19.

For more information, please visit www.PreMedInc.com or call 1.877.335.2455.

Tagged ,

First Commercial Laboratory in South Carolina Validated for COVID-19 Testing

Premier Medical Laboratory Services increases critical access to COVID-19 diagnostics

GREENVILLE, SC March 26, 2020  – Premier Medical Laboratory Services (PMLS), an industry leading diagnostic laboratory, headquartered in Greenville, South Carolina, is announcing today they are now validated for COVID-19 testing. The laboratory is currently increasing its testing capacity of 1,000 tests per day with plans to reach 28,000 per week in the coming weeks. Now available to hospitals and physicians offices throughout the United States, the test is developed under CDC guidelines for patient testing under the FDA’s Emergency Use Authorization (EUA).

Developed at PMLS’s 40,000 sqft COLA and CLIA regulated laboratory, results of this molecular diagnostic test are anticipated to be provided within 24 – 48 hours upon lab receipt of the testing sample. Lead times may extend due to volume. Assisting with PMLS’s testing capacity and quick turn around of results is their use of OnGen, a cloud-based Laboratory Information System (LIS) which allows testing orders to be entered and communicated directly to laboratory instruments. Expedited detection of the virus will enable further efficiency in response time to employ the appropriate courses of action for containment of the virus.

“We are proud of our team for working diligently around the clock so that we could attain validation status and increase access to testing, which is urgent at this time,” Kevin Murdock, Founder of Premier Medical Laboratory Services said. “Our lab is at the forefront of the most advanced technology and science available, providing cutting edge diagnostics to help flatten the curve of this global pandemic.”

According to recent statements by the FDA, rapid detection of COVID-19 cases in the United States requires wide availability of diagnostic testing to control the emergence of this rapidly spreading, severe illness. The World Health Organization has urged all countries to test every suspected case. “We have not seen an urgent enough escalation in testing, isolation and contact tracing, which is the backbone of the response,” WHO Director-General Tedros Adhanom Ghebreyesus said.

Premier Medical Laboratory Services’ COVID-19 test is a part of their comprehensive respiratory pathogen test. It is developed to determine the causation for symptoms that a patient may be experiencing, as COVID-19 can exist as a co-infection with other viruses and bacteria. These results deliver vital knowledge – ruling out and dectecting multiple causative pathogens and allowing a physician to provide the most suitable care for their patients during this critical time.

Hospitals and physicians offices can provide COVID-19 testing by clicking on the following link for easy account activation with PMLS: www.premedinc.com/covid-19

ABOUT PREMIER MEDICAL LABORATORY

Premier Medical Laboratory Services (PMLS) is a CLIA and COLA regulated laboratory based in Greenville, South Carolina focused on providing clinically meaningful results to medical practitioners. Premier Medical Laboratory Services offers a variety of highly specialized tests including: the only Type II Diabetes molecular predisposition test available in the U.S., advanced cardiovascular testing, hereditary cancer screening, carrier screening, women’s health panels, pharmacogenomics, serum allergy testing, blood wellness, Hepatitis C genotyping, respiratory pathogens, gastrointestinal pathogens, and more. In addition to its specialty programs, Premier Medical Laboratory offers a comprehensive testing menu of general chemistry, immunoassay, and hematology tests. The company also is proud to offer a patient friendly billing policy. For more information, please visit www.PreMedInc.com or call 1.877.335.2455.

Media Contact:

Kristina Loughrey

Kristina@klapublicrelations.com

864.360.5848

Tagged ,

South Carolina Medical Manufacturing Firm to Release 54,000 COVID-19 Tests Next Week

CPT Medical to increase COVID-19 diagnostics access

GREENVILLE, SC March 20, 2020  – CPT Medical, a surgical pack and kit manufacturing firm based in Greenville, SC, is now shipping COVID-19 testing kits that are available throughout the US. With 54,000 test kits in production for allocation to hospitals, nursing homes, and physician’s offices by the end of next week, CPT Medical is scheduled to release 95,000 test kits for patient testing in approximately three weeks.  

Developed in CPT Medical’s FDA registered facility under CDC guidelines, the tests offered are bulk kits for nursing homes, hospitals, laboratories, and large physician’s offices as well as individual kits for laboratories. Produced in collaboration with Premier Medical Laboratory Services, a COLA and CLIA regulated laboratory, the tests serve as a COVID-19 diagnostic testing and Respiratory Pathogen Profile (RPP) kits.

Currently in development at the CPT Medical facility for telehealth services are home testing kits to be ordered by physicians to their patients. This development will help mitigate transmission of the virus between patients and healthcare providers. Once the development process is completed for the in-home testing kits, they will not be available to the general public directly, but will be accessible by physicians only for their patients.

The World Health Organization has urged all countries to test every suspected case. “We have not seen an urgent enough escalation in testing, isolation and contact tracing, which is the backbone of the response,” WHO Director-General Tedros Adhanom Ghebreyesus said.

“Helping to provide a critical piece in containing the spread of COVID-19 is something we are very proud of,” stated Connie Liesman, CEO of CPT Medical. “The shortage in testing is something that we are on a mission to impact positively in South Carolina and the US at large. For over fifteen years we have manufactured surgical packs and kits for hospitals and surgery centers and our team is practiced in efficiently producing the highest quality tests for current needs.”   

To order COVID-19 test kits or for more information, healthcare providers can call 866-584-3713 or visit www.cptmed.com.

About CPT Medical:

CPT Medical, Inc., has manufactured surgical custom and standard procedure trays, packs, and kits assembled to fit specific needs and requirements for over 15 years. At CPT, a clinical staff is available to assist with clinical product support and surgical tray review and analysis. They specialize in joint relationships with IDN’s to establish a turnkey in-house surgical pack operation. For more information, please call 866-584-3713 or visit www.cptmed.com.

Media Contact:

Kristina Loughrey

Kristina@klapublicrelations.com 864.360.5848

Tagged ,